The U.S. Food and Drug Administration (FDA) recently published final guidance titled, “Recommendations for Evaluating Donor Eligibility Using Individual Risk-Based Questions to Reduce the Risk of HIV Transmission by Blood and Blood Products.” This groundbreaking change moves to individual donor assessments for blood donor screening, replacing the previous practice of time-based deferrals, including those for sexually active gay and bisexual men, and women who have sex with them. This document includes frequently asked questions about this change.
Posted in One-Pagers and FAQs